rs2239785
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003661.4(APOL1):c.448G>A(p.Glu150Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.789 in 1,613,690 control chromosomes in the GnomAD database, including 510,429 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_003661.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOL1 | NM_003661.4 | c.448G>A | p.Glu150Lys | missense_variant | 6/6 | ENST00000397278.8 | NP_003652.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOL1 | ENST00000397278.8 | c.448G>A | p.Glu150Lys | missense_variant | 6/6 | 1 | NM_003661.4 | ENSP00000380448 | A2 |
Frequencies
GnomAD3 genomes AF: 0.685 AC: 104059AN: 151950Hom.: 38808 Cov.: 31
GnomAD3 exomes AF: 0.791 AC: 198800AN: 251180Hom.: 80607 AF XY: 0.797 AC XY: 108255AN XY: 135778
GnomAD4 exome AF: 0.800 AC: 1168760AN: 1461622Hom.: 471605 Cov.: 76 AF XY: 0.800 AC XY: 582048AN XY: 727150
GnomAD4 genome AF: 0.685 AC: 104116AN: 152068Hom.: 38824 Cov.: 31 AF XY: 0.694 AC XY: 51587AN XY: 74340
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | This variant is associated with the following publications: (PMID: 19239905, 22239288) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 92. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at